Lithium inhibits progression of amyotrophic lateral sclerosis
This article has no abstract so we have provided the first paragraph of the full text.
Amyotrophic lateral sclerosis (ALS) has no effective treatment, and the disease normally causes death within 1–5 years of diagnosis. An Italian study has shown that lithium—which promotes autophagy and has neuroprotective effects in animal models—can slow the progression of ALS.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.